KalVista Pharmaceuticals, Inc. insider trading activity
Understanding Insider Activity at KalVista Pharmaceuticals, Inc.
Welcome to our dedicated page for KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) insider trading activity, sourced directly from the SEC Form 4 Filings. Here, you'll find the latest buying and selling activities undertaken by KalVista Pharmaceuticals, Inc.'s key insiders, providing a unique window into the company's internal sentiments.
How to Use This Data:
Below, you can view insider transactions that were reported to the SEC within the last 365 days.
While insider trading can hint at a company's prospects, it's crucial to approach this data as part of a broader investment strategy. Look for patterns over time, significant buys or sells, and consider other market factors before making investment decisions.
Scroll down to view the most recent insider transactions for KalVista Pharmaceuticals, Inc., and gain a better understanding of the confidence and considerations of those intimately tied to the company's success.
Track insider trades for KALV| Ticker | Time & Date | Filing | Link |
|---|---|---|---|
| KALV | 12:19:24 AM 11/20/2024 | Palleiko Benjamin L(CHIEF EXECUTIVE OFFICER) sold 14400 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$133344 | Filing |
| KALV | 12:18:39 AM 11/20/2024 | Yea Christopher(CHIEF DEVELOPMENT OFFICER) sold 7192 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$66597 | Filing |
| KALV | 12:18:06 AM 11/20/2024 | Audhya Paul K.(CHIEF MEDICAL OFFICER) sold 8077 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$74793 | Filing |
| KALV | 12:31:46 AM 9/11/2024 | Palleiko Benjamin L(CHIEF EXECUTIVE OFFICER) sold 7352 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$89620 | Filing |
| KALV | 12:00:20 AM 8/27/2024 | Audhya Paul K.(CHIEF MEDICAL OFFICER) sold 2135 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$26474 | Filing |
| KALV | 11:58:40 PM 8/26/2024 | Yea Christopher(CHIEF DEVELOPMENT OFFICER) sold 1916 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$23758 | Filing |
| KALV | 1:26:19 AM 8/22/2024 | Audhya Paul K.(CHIEF MEDICAL OFFICER) sold 7973 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$95755 | Filing |
| KALV | 1:25:42 AM 8/22/2024 | Palleiko Benjamin L(CHIEF EXECUTIVE OFFICER) sold 14215 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$170722 | Filing |
| KALV | 1:25:05 AM 8/22/2024 | Yea Christopher(CHIEF DEVELOPMENT OFFICER) sold 7102 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$85295 | Filing |
| KALV | 10:42:49 PM 6/10/2024 | Palleiko Benjamin L(CHIEF EXECUTIVE OFFICER) sold 7465 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$86071 | Filing |
| KALV | 9:59:02 PM 5/21/2024 | Feener Edward P.(CHIEF SCIENTIFIC OFFICER) sold 8088 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$95114 | Filing |
| KALV | 9:58:13 PM 5/21/2024 | Audhya Paul K.(CHIEF MEDICAL OFFICER) sold 13175 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$154938 | Filing |
| KALV | 9:57:09 PM 5/21/2024 | Palleiko Benjamin L(CHIEF EXECUTIVE OFFICER) sold 21959 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$258237 | Filing |
| KALV | 9:55:36 PM 5/21/2024 | Yea Christopher(CHIEF DEVELOPMENT OFFICER) sold 11610 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$136533 | Filing |
| KALV | 2:51:28 AM 2/22/2024 | Feener Edward P.(CHIEF SCIENTIFIC OFFICER) sold 28288 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$397954 | Filing |
| KALV | 2:48:58 AM 2/22/2024 | Yea Christopher(CHIEF DEVELOPMENT OFFICER) sold 12053 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$170067 | Filing |
| KALV | 2:46:54 AM 2/22/2024 | Palleiko Benjamin L(CFO, CBO) sold 22802 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$321736 | Filing |
| KALV | 2:44:15 AM 2/22/2024 | Audhya Paul K.(CHIEF MEDICAL OFFICER) sold 14295 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$201845 | Filing |
| KALV | 2:41:48 AM 2/22/2024 | Crockett Thomas Andrew(CEO) sold 24888 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$351169 | Filing |
| KALV | 9:21:06 PM 2/16/2024 | Palleiko Benjamin L(CFO, CBO) sold 40855 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$613233 | Filing |
| KALV | 9:20:08 PM 2/16/2024 | Crockett Thomas Andrew(CEO) sold 58356 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$875923 | Filing |
| KALV | 9:19:17 PM 2/16/2024 | Feener Edward P.(CHIEF SCIENTIFIC OFFICER) sold 28171 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$422846 | Filing |
| KALV | 9:18:15 PM 2/16/2024 | Yea Christopher(CHIEF DEVELOPMENT OFFICER) sold 39886 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$598688 | Filing |
| KALV | 1:11:37 AM, 2/9/2024 | Venrock Healthcare Capital Partners III, L.P. purchased 86048 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$1257827 | Filing |
| KALV | 10:55:05 PM 2/5/2024 | Crockett Thomas Andrew(CEO) sold 10000 shares of KalVista Pharmaceuticals, Inc. (KALV) for ~$162241 | Filing |
Discover the Complete Picture 🔒
Currently viewing just 6 of 55 insider filings.
Register now to dive deeper and explore the full dataset.